FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144113312> ?p ?o ?g. }

• W2144113312 endingPage "545" @default.
• W2144113312 startingPage "545" @default.
• W2144113312 abstract "Background: The herpes zoster vaccine is effective in preventing herpes zoster and postherpetic neuralgia in immunocompetent older adults. However, its safety has not been described in depth. Objective: To describe local adverse effects and short- and long-term safety profiles of herpes zoster vaccine in immunocompetent older adults. Design: Randomized, placebo-controlled trial with enrollment from November 1998 to September 2001 and follow-up through April 2004 (mean, 3.4 years). A Veterans Affairs Coordinating Center generated the permutated block randomization scheme, which was stratified by site and age. Participants and follow-up study personnel were blinded to treatment assignments. (ClinicalTrials.gov registration number: NCT00007501) Setting: 22 U.S. academic centers. Participants: 38 546 immunocompetent adults 60 years or older, including 6616 who participated in an adverse events substudy. Intervention: Single dose of herpes zoster vaccine or placebo. Measurements: Serious adverse events and rashes in all participants and inoculation-site events in substudy participants during the first 42 days after inoculation. Thereafter, vaccination-related serious adverse events and deaths were monitored in all participants, and hospitalizations were monitored in substudy participants. Results: After inoculation, 255 (1.4%) vaccine recipients and 254 (1.4%) placebo recipients reported serious adverse events. Local inoculation-site side effects were reported by 1604 (48%) vaccine recipients and 539 (16%) placebo recipients in the substudy. A total of 977 (56.6%) of the vaccine recipients reporting local side effects were aged 60 to 69 years, and 627 (39.2%) were older than 70 years. After inoculation, herpes zoster occurred in 7 vaccine recipients versus 24 placebo recipients. Long-term follow-up (mean, 3.39 years) showed that rates of hospitalization or death did not differ between vaccine and placebo recipients. Limitations: Participants in the substudy were not randomly selected. Confirmation of reported serious adverse events with medical record data was not always obtained. Conclusion: Herpes zoster vaccine is well tolerated in older, immunocompetent adults. Primary Funding Source: Cooperative Studies Program, Department of Veterans Affairs, Office of Research and Development; grants from Merck to the Veterans Affairs Cooperative Studies Program; and the James R. and Jesse V. Scott Fund for Shingles Research." @default.
• W2144113312 created "2016-06-24" @default.
• W2144113312 creator A5002479274 @default.
• W2144113312 creator A5003310026 @default.
• W2144113312 creator A5009725215 @default.
• W2144113312 creator A5015242509 @default.
• W2144113312 creator A5017607205 @default.
• W2144113312 creator A5020436097 @default.
• W2144113312 creator A5022885582 @default.
• W2144113312 creator A5040474181 @default.
• W2144113312 creator A5050785216 @default.
• W2144113312 creator A5051264386 @default.
• W2144113312 creator A5051550648 @default.
• W2144113312 creator A5057334801 @default.
• W2144113312 creator A5058144983 @default.
• W2144113312 creator A5064245686 @default.
• W2144113312 creator A5067212196 @default.
• W2144113312 creator A5072978528 @default.
• W2144113312 date "2010-05-04" @default.
• W2144113312 modified "2023-10-09" @default.
• W2144113312 title "Safety of Herpes Zoster Vaccine in the Shingles Prevention Study" @default.
• W2144113312 cites W1989240299 @default.
• W2144113312 cites W1991129383 @default.
• W2144113312 cites W1997628339 @default.
• W2144113312 cites W2054751322 @default.
• W2144113312 cites W2096848795 @default.
• W2144113312 cites W2122633654 @default.
• W2144113312 cites W2127077268 @default.
• W2144113312 cites W2127608748 @default.
• W2144113312 cites W2131041950 @default.
• W2144113312 cites W2146890931 @default.
• W2144113312 cites W2161563980 @default.
• W2144113312 cites W2172231623 @default.
• W2144113312 cites W2314176578 @default.
• W2144113312 cites W2333762130 @default.
• W2144113312 cites W184373549 @default.
• W2144113312 doi "https://doi.org/10.7326/0003-4819-152-9-201005040-00004" @default.
• W2144113312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20439572" @default.
• W2144113312 hasPublicationYear "2010" @default.
• W2144113312 type Work @default.
• W2144113312 sameAs 2144113312 @default.
• W2144113312 citedByCount "106" @default.
• W2144113312 countsByYear W21441133122012 @default.
• W2144113312 countsByYear W21441133122013 @default.
• W2144113312 countsByYear W21441133122014 @default.
• W2144113312 countsByYear W21441133122015 @default.
• W2144113312 countsByYear W21441133122016 @default.
• W2144113312 countsByYear W21441133122017 @default.
• W2144113312 countsByYear W21441133122018 @default.
• W2144113312 countsByYear W21441133122019 @default.
• W2144113312 countsByYear W21441133122020 @default.
• W2144113312 countsByYear W21441133122021 @default.
• W2144113312 countsByYear W21441133122022 @default.
• W2144113312 countsByYear W21441133122023 @default.
• W2144113312 crossrefType "journal-article" @default.
• W2144113312 hasAuthorship W2144113312A5002479274 @default.
• W2144113312 hasAuthorship W2144113312A5003310026 @default.
• W2144113312 hasAuthorship W2144113312A5009725215 @default.
• W2144113312 hasAuthorship W2144113312A5015242509 @default.
• W2144113312 hasAuthorship W2144113312A5017607205 @default.
• W2144113312 hasAuthorship W2144113312A5020436097 @default.
• W2144113312 hasAuthorship W2144113312A5022885582 @default.
• W2144113312 hasAuthorship W2144113312A5040474181 @default.
• W2144113312 hasAuthorship W2144113312A5050785216 @default.
• W2144113312 hasAuthorship W2144113312A5051264386 @default.
• W2144113312 hasAuthorship W2144113312A5051550648 @default.
• W2144113312 hasAuthorship W2144113312A5057334801 @default.
• W2144113312 hasAuthorship W2144113312A5058144983 @default.
• W2144113312 hasAuthorship W2144113312A5064245686 @default.
• W2144113312 hasAuthorship W2144113312A5067212196 @default.
• W2144113312 hasAuthorship W2144113312A5072978528 @default.
• W2144113312 hasBestOaLocation W21441133121 @default.
• W2144113312 hasConcept C126322002 @default.
• W2144113312 hasConcept C142724271 @default.
• W2144113312 hasConcept C168563851 @default.
• W2144113312 hasConcept C187212893 @default.
• W2144113312 hasConcept C197934379 @default.
• W2144113312 hasConcept C203014093 @default.
• W2144113312 hasConcept C204787440 @default.
• W2144113312 hasConcept C22070199 @default.
• W2144113312 hasConcept C2522874641 @default.
• W2144113312 hasConcept C27081682 @default.
• W2144113312 hasConcept C2777107010 @default.
• W2144113312 hasConcept C2778866549 @default.
• W2144113312 hasConcept C2779001537 @default.
• W2144113312 hasConcept C42219234 @default.
• W2144113312 hasConcept C71924100 @default.
• W2144113312 hasConceptScore W2144113312C126322002 @default.
• W2144113312 hasConceptScore W2144113312C142724271 @default.
• W2144113312 hasConceptScore W2144113312C168563851 @default.
• W2144113312 hasConceptScore W2144113312C187212893 @default.
• W2144113312 hasConceptScore W2144113312C197934379 @default.
• W2144113312 hasConceptScore W2144113312C203014093 @default.
• W2144113312 hasConceptScore W2144113312C204787440 @default.
• W2144113312 hasConceptScore W2144113312C22070199 @default.
• W2144113312 hasConceptScore W2144113312C2522874641 @default.
• W2144113312 hasConceptScore W2144113312C27081682 @default.
• W2144113312 hasConceptScore W2144113312C2777107010 @default.

• next